Skip to content
DataLookout
Menu

ENDO-LANDSCAPENCT05547607

Clinical and Diagnostic Features of Endocarditis

StatusCompleted
PhaseNot specified
Primary completion
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 6 versions: 5 with changes below, 1 re-verified with no change. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 4 words Show 5 more changesShow less
    • Trial completed
    • Final enrollment: 938 participants (planned 500)
    • Primary completion date changed from estimate of Jun 30, 2026 to Nov 4, 2026
    • Site details revised
    • Publications: details revised at 1 of 1 entry
  2. Notable Primary completion date: Sep 30, 2025 to Jun 30, 2026
    • Study completion date: Sep 30, 2026 to Jun 30, 2028
    v5
  3. Notable Primary completion date: Sep 30, 2024 to Sep 30, 2025
    • Study completion date: Sep 30, 2025 to Sep 30, 2026
    v4
  4. Minor Secondary endpoints: details revised at 1 of 5 entriesv2
  5. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

incidence of endocarditis
Timeframe: 1 year

Secondary (5)

Appropriateness of requests for echocardiography to exclude endocarditis
All-cause mortality of surgically treated endocarditis
All-cause mortality of medically managed endocarditis
Cerebrovascular accident
Re-infection in invasively treated endocarditis

Arms and interventions

definite or high suspicion endocarditis

All consecutive patients referred for an echocardiography (transthoracic or transesophageal approach) with a high suspicion of endocarditis and those with a confirmed diagnosis of endocarditis independently by the request will be eligible for the study.

negative examination with low suspicion of endocarditis

For patients with no evidence of endocarditis on their echocardiogram, data on the following will be collected: i) risk factors for endocarditis; i) size, type and position of valve prosthesis or other devices if present; iii) Duke criteria verification.

Diagnostic tests: advanced cardiac imaging

Sites

1 site in 1 country

  • University Hospital of FerraraCona, Ferrara, Italy